Mini Drug Pump for Ophthalmic Use
暂无分享,去创建一个
Mark S Humayun | Po-Ying Li | Ellis Meng | Saloomeh Saati | Rohit Varma | Ronalee Lo | M. Humayun | E. Meng | R. Varma | S. Saati | R. Lo | Po-Ying Li
[1] A. Manz,et al. Micro total analysis systems. Recent developments. , 2004, Analytical chemistry.
[2] A. Dash,et al. Therapeutic applications of implantable drug delivery systems. , 1998, Journal of pharmacological and toxicological methods.
[3] M. Phillip,et al. Use of Insulin Pump Therapy in the Pediatric Age-Group , 2007, Diabetes Care.
[4] James D. Weiland,et al. Scalable high lead-count parylene package for retinal prostheses , 2006 .
[5] D. Metrikin,et al. Intravitreal drug administration with depot devices , 1994, Current opinion in ophthalmology.
[6] R. Zare,et al. Construction of microfluidic chips using polydimethylsiloxane for adhesive bonding. , 2005, Lab on a chip.
[7] A. Bazarbachi,et al. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. , 2006, American journal of ophthalmology.
[8] P. Sado,et al. Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.
[9] Mark S Humayun,et al. A refillable microfabricated drug delivery device for treatment of ocular diseases. , 2008, Lab on a chip.
[10] Michael J Cima,et al. Electronic MEMS for triggered delivery. , 2004, Advanced drug delivery reviews.
[11] P. Hoyng,et al. Pharmacological therapy for glaucoma: a review. , 2000, Drugs.
[12] A. Berg,et al. Micro Total Analysis Systems: Microfluidic Aspects, Integration Concept and Applications , 1997 .
[13] Po-Ying Li,et al. An electrochemical intraocular drug delivery device , 2008, 2007 IEEE 20th International Conference on Micro Electro Mechanical Systems (MEMS).
[14] S. Shoji. Micro Total Analysis Systems , 1999 .
[15] E. Lad,et al. Minimizing the risk of endophthalmitis following intravitreal injections. , 2006, Comprehensive ophthalmology update.
[16] C. Kuo,et al. Vascular endothelial growth factor: biology and therapeutic applications. , 2007, The international journal of biochemistry & cell biology.
[17] C. R. Ethier,et al. Ocular biomechanics and biotransport. , 2004, Annual review of biomedical engineering.
[18] H. D. Cavanagh,et al. In Vivo Confocal Microscopic Studies of Endothelial Wound Healing in Rabbit Cornea , 1993, Cornea.
[19] R. Avery,et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. , 2006, Ophthalmology.
[20] K Miyamoto,et al. Transscleral delivery of bioactive protein to the choroid and retina. , 2000, Investigative ophthalmology & visual science.
[21] Yasmin Sultana,et al. Review of ocular drug delivery. , 2006, Current drug delivery.
[22] Ming Yang,et al. Integrated microsystems for controlled drug delivery. , 2004, Advanced drug delivery reviews.
[23] A. Ozkiriş,et al. Complications of intravitreal injection of triamcinolone acetonide. , 2005, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[24] N. Davies,et al. Biopharmaceutical Considerations In Topical Ocular Drug Delivery , 2000, Clinical and experimental pharmacology & physiology.
[25] E. G. Olsen,et al. THE HEALING OF RABBIT CORNEAL ENDOTHELIUM , 1984, Acta ophthalmologica.
[26] D L Van Horn,et al. Regenerative capacity of the corneal endothelium in rabbit and cat. , 1977, Investigative ophthalmology & visual science.
[27] M. Humayun,et al. A Passive Refillable Intraocular MEMS Drug Delivery Device , 2006, 2006 International Conference on Microtechnologies in Medicine and Biology.
[28] D. Hinton,et al. In vivo models of proliferative vitreoretinopathy , 2007, Nature Protocols.
[29] T. Deckert,et al. Evaluation of insulin pump treatment under routine conditions. , 1987, Diabetes research and clinical practice.
[30] Shuichi Shoji,et al. Fluids for Sensor Systems , 1998 .
[31] A. Berg,et al. Micro Total Analysis Systems , 1995 .
[32] Rhea Lloyd,et al. Food and Drug Administration approval process for ophthalmic drugs in the US , 2008, Current opinion in ophthalmology.
[33] W. Alward,et al. Medical management of glaucoma. , 1998, The New England journal of medicine.
[34] E. Pels,et al. Biocompatibility of trypan blue with human corneal cells. , 2004, Archives of ophthalmology.
[35] Chang Sik Kim,et al. Changes in corneal endothelial cell density and morphology after Ahmed glaucoma valve implantation during the first year of follow up , 2008, Clinical & experimental ophthalmology.
[36] H F Edelhauser,et al. Drug delivery for posterior segment eye disease. , 2000, Investigative ophthalmology & visual science.
[37] K. Lim. Corneal Endothelial Cell Damage from Glaucoma Drainage Device Materials , 2003, Cornea.
[38] I. Scott,et al. INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR CENTRAL AND HEMICENTRAL RETINAL VEIN OCCLUSIONS: IBeVO Study , 2007, Retina.
[39] J. Hsu,et al. Drug delivery methods for posterior segment disease , 2007, Current opinion in ophthalmology.
[40] J W Shell,et al. Ophthalmic drug delivery systems , 1984, Survey of ophthalmology.